Catheter to thermally classify atherosclerotic plaque

Information

  • Research Project
  • 7125594
  • ApplicationId
    7125594
  • Core Project Number
    R44HL067473
  • Full Project Number
    5R44HL067473-04
  • Serial Number
    67473
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/2001 - 23 years ago
  • Project End Date
    7/31/2007 - 17 years ago
  • Program Officer Name
    FILART, ROSEMARIE
  • Budget Start Date
    8/1/2006 - 18 years ago
  • Budget End Date
    7/31/2007 - 17 years ago
  • Fiscal Year
    2006
  • Support Year
    4
  • Suffix
  • Award Notice Date
    8/30/2006 - 18 years ago

Catheter to thermally classify atherosclerotic plaque

DESCRIPTION (provided by applicant): The purpose of this study will be to detect the prevalence and prognostic value of plaque temperature heterogeneity in diabetic patients undergoing stent implantation. The objective is to develop and commercialize an intraluminal Thermal Sensing System (TSS) for taking surface temperature measurements of atherosclerotic plaque lesions within the walls of coronary arteries with the goal that current and future means to prevent coronary events can be implemented selectively. The system comprises an invasive catheter and an external instrument. The device has been validated in vitro and in vivo. A pilot human study involving patients undergoing angioplasty for medically indicated reasons was completed successfully. Specific Aims for the proposed SBIR Phase II are: [1] Advance the current intraluminal TSS toward a commercially viable product - change to thermocouples, improve catheter flexibility, reduce sensing element profile, integrate an occlusion feature - followed by revalidation of System safety and performance. [2] Demonstrate in a human clinical trial the predictive value of plaque surface temperature for future ischemic events and validate the performance of the TSS. After this grant we have plans in place to commercialize the technology including design for manufacturability, additional clinical studies, and a market development strategy for this exciting and useful new diagnostic device.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    109589
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:109589\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ACCUMED SYSTEMS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ANN ARBOR
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    481039140
  • Organization District
    UNITED STATES